Warning letter
Med Prep Consulting, Inc.: warning letter of Oct 2, 2001
FDA warning letter UCM178623 · New Jersey District Office
Key facts
| Reference number | UCM178623 |
|---|---|
| Company | Med Prep Consulting, Inc. |
| Subject | Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated |
| Issue date | Oct 2, 2001 |
| Posted date | Oct 2, 2001 |
| Issuing office | New Jersey District Office |
| Product type | Drugs |
| Country | 3 |
| Inspection city | Ocean |
| Inspection ZIP | 07712-3192 |
| Inspection start date | Apr 9, 2001 |
| Letter on fda.gov | web.archive.org |
At a glance
- NAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: